Status:

COMPLETED

Are Stabilization Exercises Effective After Epidural Steroid Injection in Patients With Cervical Radiculopathy?

Lead Sponsor:

Marmara University

Conditions:

Pain, Neck

Cervical Radiculopathy

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Cervical radiculopathy was first described in 1943 by researchers named Semmes and Murphy, years later than lumbosacral radiculopathy. It is a neurological condition caused by dysfunction in the cervi...

Detailed Description

Many studies in the literature separately investigate the effectiveness of Cervical Interlaminar Epidural Steroid Injection (CIESI) in radiculopathy due to cervical disc herniation or the effectivenes...

Eligibility Criteria

Inclusion

  • Between the ages of 18-65
  • Cervical radiculopathy has caused neck and arm pain for at least three months.
  • Sign a consent form and volunteer to take part in the study.

Exclusion

  • Previous surgical/interventional procedure for the cervical region
  • Presence of other musculoskeletal disorders (such as lateral epicondylitis, tendinitis, entrapment neuropathy) that may cause diagnostic confusion in terms of pain pattern and localization
  • Signs of trauma, fracture, malignancy, or active infection
  • Rheumatological (RA, AS, etc.), endocrinological (such as osteoporosis, Paget's disease), or another systemic disease that may change the anatomical or physiological structure of the relevant regions Presence of coagulopathy
  • History of whiplash injury, cervical spinal stenosis, cervical spondylosis
  • Being pregnant and breastfeeding
  • Presence of mental deterioration or psychiatric/neurological disease that can affect the flow of the study.
  • Having a history of allergic reactions to the injectables that will be used.
  • Presence of cardiopulmonary disease that may lead to exercise intolerance (heart failure, chronic obstructive pulmonary disease, etc.)
  • Failure to implement the exercise program regularly.

Key Trial Info

Start Date :

March 23 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 29 2023

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05307211

Start Date

March 23 2022

End Date

April 29 2023

Last Update

May 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Marmara University, Faculty of Medicine

Istanbul, Pendik, Turkey (Türkiye), 34890